Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. - Wikidata - awgldk - TriplyDB

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.

http://www.wikidata.org/entity/Q36287668

about

Side effects of yttrium-90 radioembolization Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Yttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives X-ray-induced shortwave infrared biomedical imaging using rare-earth nanoprobes.Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma Rare Earth Nanoprobes for Functional Biomolecular Imaging and Theranostics.Temporary arterial balloon occlusion as an adjunct to Yttrium-90 radioembolization.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Rare-earth-doped biological composites as in vivo shortwave infrared reporters Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease A low-interaction automatic 3D liver segmentation method using computed tomography for selective internal radiation therapy.Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial Positron emission tomography image-guided drug delivery: current status and future perspectives.Embolotherapy in the management of hepatocellular carcinoma.[90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases "What goes round comes round"Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.Research reporting standards for radioembolization of hepatic malignancies.Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates Radioembolization for primary and metastatic liver cancer.Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies Celiac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience.Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review Radionuclide carriers for targeting of cancer.Y-90 microshperes in the treatment of unresectable hepatocellular carcinoma.Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.

P2860

Q26821887-C761F964-B1FA-4189-A735-BE19B6FEE23A Q26852174-DD6CC0AE-46A6-460B-8ECB-16F0E139AEFE Q26997064-52919EF6-6D5C-4C2F-9B71-2E9E83F1402D Q27023616-EA0BE4F0-EA90-45BF-9737-C354CF6547C5 Q27335168-D69BCC15-5852-4DC7-A89F-4453900D21AB Q28314897-E05B2114-1ADF-46CF-9EE9-94BC7AAB949B Q30410841-9B212729-5E32-472F-9892-4E4389F8086E Q30456316-CFE97591-62F4-46A9-B51C-CFB1821C9E21 Q30468280-A5023DB0-D841-4E18-A741-5ED56D8CAFB4 Q30542410-7D5FF678-75D4-41A8-A8AB-A9655CDC9731 Q33704156-D40ECD84-01C9-417A-8C3B-D724D35D8060 Q33715683-72CF2A87-DCA9-4DB2-8C6E-21F07F9D666B Q33851393-548201C5-4DC5-457D-8F81-A56627D71E92 Q33870879-2C721486-AB49-425B-9680-44CFBE4E5618 Q33930392-8C2EF6E8-7F33-43D3-A580-5706B8A48638 Q33991842-AC6B132D-F50B-4336-A759-CFE3AAE60F8E Q34446108-53F719BF-6A67-4B56-904A-06FD04EAC42B Q34563655-3542FFB3-DBA5-47A4-8224-4F4B80B99785 Q34866445-6695A187-9EBB-4AA8-9CFB-1DCDBE4E477C Q34991326-BA161D9E-3C95-4216-8E80-424274A76A22 Q35094057-1F9118C3-EC88-4AE0-93EE-B440ECE78241 Q35111887-A655F33A-CD9D-42AE-80CF-40C42182B460 Q35206768-EF233C9F-EA83-4DD5-8ED0-FD8F889E886C Q35564038-6E8BC091-16B3-4865-9952-15F93B4132E5 Q35658025-2A5142F9-7230-4AC1-92F8-61BBECBB3362 Q35721324-A617194E-056B-4B6B-9BB7-8823B5B34020 Q36062588-A6B90364-0A0F-4B10-902C-8ACB0481DF0A Q36163785-9FC09F29-EE4C-4F87-AF7A-289C2017C04C Q36470428-A2846E41-DE79-4A3D-A904-EAA331A70F6B Q36482781-0CDE56EE-043A-4898-A8FA-DE16C0F8FB0B Q36728823-0FDAFBA4-CA17-42D5-905D-F98AECF96FB7 Q36738344-F58CC97C-69A5-44A7-8971-2AA3469D4E5A Q36899620-17D47D61-730A-41AD-BABB-B476F257E18B Q36961922-2A748556-D35C-411A-A38C-C982852FBE20 Q36980633-DC6F1FCE-4692-4B39-8B44-1049E934FE9B Q37113543-54C66EAD-C0F1-4C3C-8452-BE70FA9B5540 Q37237705-BB45D876-8637-4077-B7EF-7F791A7AE046 Q37243546-83904B19-389F-44F8-9791-FB6A55706DED Q37326857-E62ADD6F-466A-434F-803E-8ADFC6D8594C Q37353096-BC28B26F-0E44-4788-930E-2E2FF0EEF555

P2860

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.

http://www.wikidata.org/entity/Q36287668

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Yttrium-90 microsphere therapy ...... , and potential complications.

@ast

Yttrium-90 microsphere therapy ...... , and potential complications.

@en

type

label

Yttrium-90 microsphere therapy ...... , and potential complications.

@ast

Yttrium-90 microsphere therapy ...... , and potential complications.

@en

prefLabel

Yttrium-90 microsphere therapy ...... , and potential complications.

@ast

Yttrium-90 microsphere therapy ...... , and potential complications.

@en

P1433

Q36287668-CA3195D9-5FE3-4B93-8683-C3512C43168C

P1476

Q36287668-D55AFAF3-A450-4EC4-8606-63BD16646855

P2093

Q36287668-40CD4B07-D691-458F-8214-8F001643C663

Q36287668-4166F842-F798-42A8-BD1D-157B23443692

Q36287668-5815E842-9E66-4A49-BD6F-E5863DC0BF61

Q36287668-8335C373-B424-4440-AFD9-AD72A904CA6F

Q36287668-9F65E844-175F-492C-9DB4-88F2F0C9EDF0

Q36287668-BACD1393-E56E-4DE1-8024-692FC090009E

Q36287668-C8B0C9F9-736B-435F-883F-327D21A0D4DD

Q36287668-CD6F4171-9911-43CD-BD7B-093D9E22333C

Q36287668-D512DFF8-6B1E-401A-9E41-8BBBA9E2DC03

Q36287668-F09856E7-4ED8-4F12-B9A4-78B48CF8D170

P304

Q36287668-13D8F8ED-57C5-46D8-BCFD-63414C072F82

P31

Q36287668-468EF9E8-27E9-4223-A257-AE6403781C86

P356

Q36287668-080F1908-1168-4004-89E5-1D531EE9EEF0

P478

Q36287668-AE5B7C9A-AFF7-486B-B670-7A081F907F39

P577

Q36287668-30106206-8BC6-43E7-BD74-9C2B1752AC9E

P5875

Q36287668-EA651051-ED9B-47B2-A166-9FBAD1762E84

P698

Q36287668-1B9D1F5D-0BA4-4DCD-9F4D-0D40AE977796

P921

Q36287668-299F4E0A-1115-4A69-9D39-573EA6000875

P356

P1433

P1476

Yttrium-90 microsphere therapy ...... , and potential complications.

@en

P2093

Alan Cohen

http://www.w3.org/2001/XMLSchema#string

Andrew S Kennedy

http://www.w3.org/2001/XMLSchema#string

David C Madoff

http://www.w3.org/2001/XMLSchema#string

Douglas M Coldwell

http://www.w3.org/2001/XMLSchema#string

Janio Szklaruk

http://www.w3.org/2001/XMLSchema#string

Kamran Ahrar

http://www.w3.org/2001/XMLSchema#string

Marshall E Hicks

http://www.w3.org/2001/XMLSchema#string

Michael J Wallace

http://www.w3.org/2001/XMLSchema#string

Ravi Murthy

http://www.w3.org/2001/XMLSchema#string

Rodolfo Nunez

http://www.w3.org/2001/XMLSchema#string

P304

S41-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RG.25SI055515

http://www.w3.org/2001/XMLSchema#string

P478

25 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7537915

http://www.w3.org/2001/XMLSchema#string

P698

16227496

http://www.w3.org/2001/XMLSchema#string

P921